-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Reinstates Underweight on Emergent BioSolutions

Benzinga·08/21/2026 19:18:09
Listen to the news
JP Morgan analyst Jessica Fye reinstates Emergent BioSolutions (NYSE:EBS) with a Underweight.